![Chemical structure of 2-[2-[1-(4-chloro-2,3,5,6-tetradeuteriobenzoyl)-5-methoxy-2-methylindol-3-yl]acetyl]oxyacetic acid, CAS 53164-05-9](https://api.angenesci.com/structure/2075/53164-05-9.png)
无数据
无数据
无数据
| CAS Number | 53164-05-9 |
| Catalog Number | AG00ILOH(AGN-PC-07Y458) |
| Chemical Name | 2-[2-[1-(4-chloro-2,3,5,6-tetradeuteriobenzoyl)-5-methoxy-2-methylindol-3-yl]acetyl]oxyacetic acid |
| EC Number | 258-403-4 |
| IUPAC Name | 2-[2-[1-(4-chlorobenzoyl)-5-methoxy-2-methylindol-3-yl]acetyl]oxyacetic acid |
| InChI | InChI=1S/C21H18ClNO6/c1-12-16(10-20(26)29-11-19(24)25)17-9-15(28-2)7-8-18(17)23(12)21(27)13-3-5-14(22)6-4-13/h3-9H,10-11H2,1-2H3,(H,24,25) |
| InChI Key | FSQKKOOTNAMONP-UHFFFAOYSA-N |
| MDL Number | MFCD00151473 |
| Molecular Formula | C21H18ClNO6 |
| Molecular Weight | 415.8237 |
| NSC Number | 757413 |
| SMILES | COc1ccc2c(c1)c(CC(=O)OCC(=O)O)c(n2C(=O)c1ccc(cc1)Cl)C |
| UNII | 5V141XK28X |
| Synonyms | acemetacin,
Acemetacin Heumann,
Acemetacin intermuti,
acemetacin monohydrate,
acemetacin sodium,
Acemetacin Stada,
acemetacin von ct,
Acemetadoc,
Acephlogont,
Azeat,
Emflex,
Espledol,
indomethacin carboxymethyl ester,
Oldan,
Rantodil,
Rantudil,
TVX 1322,
acemetacin,
53164-05-9,
Rantudil,
Emflex,
Acemetacinum,
Acemetacina,
Acemetacine,
Acemix,
Aximeixin,
Rheumibis,
Bay f 4975,
indomethacin carboxymethyl ester,
Acemetacine [INN-French],
Acemetacinum [INN-Latin],
Acemetacina [INN-Spanish],
TVX 3322,
K-708,
UNII-5V141XK28X,
K 708,
indometacin glycolic ester,
EINECS 258-403-4,
indomethacin glycolic ester,
BRN 0501672,
C21H18ClNO6,
indometacin carboxymethyl ester,
1H-Indole-3-acetic acid, 1-(4-chlorobenzoyl)-5-methoxy-2-methyl-, carboxymethyl ester,
CHEMBL189171,
CHEBI:31162,
FSQKKOOTNAMONP-UHFFFAOYSA-N,
5V141XK28X,
MFCD00151473,
NCGC00016868-09,
CAS-53164-05-9,
((1-(4-Chlorobenzoyl)-5-methoxy-2-methylindol-3-yl)acetoxy)acetic acid,
DSSTox_CID_2540,
(1-(p-Chlorbenzoyl)-5-methoxy-2-methylindol-3-acetoxy)essigsaeure [German],
2-(2-(1-(p-Chlorobenzoyl)-5-methoxy-2-methylindol-3-yl)acetoxy)acetic acid,
1-(4-Chlorobenzoyl)-5-methoxy-2-methyl-1H-indole-3-acetic acid carboxymethyl ester,
DSSTox_RID_76618,
DSSTox_GSID_22540,
Rantodil,
1-(p-Chlorobenzoyl)-5-methoxy-2-methylindole-3-acetic acid ester with glycolic acid,
1-[p-Chlorobenzoyl]-5-methoxy-2-methylindole-3-acetic acid carboxymethyl ester,
2-(2-(1-(4-chlorobenzoyl)-5-methoxy-2-methyl-1H-indol-3-yl)acetoxy)acetic acid,
2-[2-[1-(4-chlorobenzoyl)-5-methoxy-2-methylindol-3-yl]acetyl]oxyacetic acid,
SMR000058409,
SR-01000000070,
TVX 1322,
Acemetacin [BAN:INN:JAN],
Acemetacin [INN:BAN:JAN],
Solart,
acemetacin-emflex,
{[1-(4-chlorobenzoyl)-5-methoxy-2-methylindol-3-yl]acetoxy}acetic acid,
1-(p-Chlorobenzoyl)-5-methoxy-2-methylindole-3-acetic acid carboxymethyl ester,
Rantudil (TN),
Prestwick_669,
Acemetacin (Emflex),
Spectrum_000428,
AC1L1CNQ,
Prestwick0_000296,
Prestwick1_000296,
Prestwick2_000296,
Prestwick3_000296,
Spectrum2_001162,
Spectrum3_001868,
Spectrum4_000803,
Spectrum5_001385,
Acemetacin (JP17/INN),
{2-[1-(4-chlorbenzoyl)-5-methoxy-2-methyl-1h-indol-3-yl]acetoxy}essigs,
AC1Q3N7Y,
Bay-f-4975,
SCHEMBL23843,
BSPBio_000232,
BSPBio_003316,
KBioGR_001285,
KBioSS_000908,
5-22-05-00241 (Beilstein Handbook Reference),
MLS000028440,
MLS006010622,
DivK1c_000490,
SPECTRUM1500666,
SPBio_001143,
SPBio_002451,
Acemetacin, analytical standard,
BPBio1_000256,
DTXSID7022540,
CTK8B3535,
HMS501I12,
KBio1_000490,
KBio2_000908,
KBio2_003476,
KBio2_006044,
KBio3_002818,
KS-00000FKT,
NINDS_000490,
HMS1568L14,
HMS1921A08,
HMS2090E21,
HMS2095L14,
HMS2230G08,
HMS3372K20,
HMS3656E22,
HMS3712L14,
Pharmakon1600-01500666,
ZINC601272,
BCP13127,
HY-B0482,
TVX-1322,
Tox21_113473,
(1-(p-Chlorbenzoyl)-5-methoxy-2-methylindol-3-acetoxy)essigsaeure,
ANW-42684,
BDBM50336272,
CCG-39550,
NSC757413,
s2602,
AKOS015895194,
Tox21_113473_1,
AB03974,
API0001356,
CS-2597,
DB13783,
MCULE-3371205328,
NSC-757413,
TV-1322,
IDI1_000490,
NCGC00016868-01,
NCGC00016868-02,
NCGC00016868-03,
NCGC00016868-04,
NCGC00016868-05,
NCGC00016868-06,
NCGC00016868-07,
NCGC00016868-08,
NCGC00016868-11,
NCGC00016868-12,
NCGC00022084-03,
NCGC00022084-04,
NCGC00022084-05,
NCGC00022084-06,
NCGC00022084-07,
AK546748,
AN-25630,
CC-23639,
LS-82122,
SC-66348,
SBI-0051585.P002,
AB2000691,
A2452,
AB00052149,
FT-0630659,
ST50993919,
SW196824-3,
D01582,
AB00052149-15,
AB00052149_16,
AB00052149_17,
164A059,
C-21993,
I06-0330,
SR-01000000070-2,
SR-01000000070-3,
BRD-K67563174-001-05-1,
BRD-K67563174-001-09-3,
1-[P-CHLOROBENZOYL]-5-METHOXY-2-METHYLINDOLE-3-ACE,
Acemetacin, European Pharmacopoeia (EP) Reference Standard,
[1-(4-Chlorobenzoyl)-5-methoxy-2-methylindol-3-yl]acetoxyacetic Acid,
[1-(p-Chlorobenzoyl)-5-methoxy-2-methyl-3-indoleacetoxy]-acetic acid,
({2-[1-(4-chlorobenzoyl)-5-methoxy-2-methylindol-3-yl]acetyl}oxy)acetic acid,
[({1-[(4-chlorophenyl)carbonyl]-5-methoxy-2-methyl-1H-indol-3-yl}acetyl)oxy]acetic acid,
[1-(4-Chloro-benzoyl)-5-methoxy-2-methyl-1H-indol-3-yl]-acetic acid carboxymethyl ester,
{2-[1-(4-chlorobenzoyl)-5-methoxy-2-methyl-1H-indol-3-yl]acetoxy}acetic acid,
1-(4-Chlorobenzoyl)-5-methoxy-2-methylindole-3-acetic Acid Carboxymethyl Ester,
1-[p-Chlorobenzoyl]-5-methoxy- 2-methylindole-3-acetic acid carboxymethyl ester,
1H-Indole-3-aceticacid, 1-(4-chlorobenzoyl)-5-methoxy-2-methyl-, carboxymethyl ester,
2-(2-(1-((4-chlorophenyl)carbonyl)-5-methoxy-2-methylindol-3-yl)acetyloxy)acetic acid,
2-(2-{1-[(4-chlorophenyl)carbonyl]-5-methoxy-2-methylindol-3-yl}acetyloxy)acet ic acid,
2-[2-[1-(4-chlorobenzoyl)-5-methoxy-2-methyl-indol-3-yl]acetyl]oxyacetic acid,
[({1-[(4-chlorophenyl)carbonyl]-2-methyl-5-(methyloxy)-1H-indol-3-yl}acetyl)oxy]acetic acid,
2-[2-[1-(4-chloro-2,3,5,6-tetradeuteriobenzoyl)-5-methoxy-2-methylindol-3-yl]acetyl]oxyacetic acid,
acemet,
acemethacin,
acemethazine,
Acemetadoc,
Acephlogont,
Espledol,
Azeat,
Oldan,
Acemetacin Stada,
acemetacin sodium,
acemetacin von ct,
Acemetacin Heumann,
Acemetacin intermuti,
acemetacin monohydrate,
C21-H18-Cl-N-O6,
CID1981,
KST-1B5087,
AR-1A9445,
ACN-037622,
CS-T-46896,
B1440,
A11692,
Acemetacin, 98%, COX inhibitor - 25G 25g,
C026784,
[[1-(4-chlorobenzoyl)-5-methoxy-2-methylindol-3-yl]acetoxy]acetic acid,
54063-31-9,
|
| Complexity | 620 |
| Compound Is Canonicalized | Yes |
| Covalently-Bonded Unit Count | 1 |
| Defined Atom Stereocenter Count | 0 |
| Defined Bond Stereocenter Count | 0 |
| Exact Mass | 415.082g/mol |
| Formal Charge | 0 |
| Heavy Atom Count | 29 |
| Hydrogen Bond Acceptor Count | 6 |
| Hydrogen Bond Donor Count | 1 |
| Isotope Atom Count | 0 |
| Molecular Weight | 415.826g/mol |
| Monoisotopic Mass | 415.082g/mol |
| Rotatable Bond Count | 7 |
| Topological Polar Surface Area | 94.8A^2 |
| Undefined Atom Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| XLogP3 | 4.2 |
| Symbol: | |
| Hazard Class | 6.1 |
| Hazard statements | H300-H310-H330 |
| Packing Group | Ⅱ |
| Precautionary statements | P260-P264-P280-P284-P301+P310-P302+P350 |
| UN Code | UN 2811 |
| Chemical Name: | Batch Number: | |
| Chemical Structure: | CAS Registry No: | |
| Product ID: | ||
| Manufacture Date: | ||
| Storage Temperature: | ||
| Formula: | ||
| Molecular Weight: | ||
| Quantity: |
| Test: | Result: |

